The Effect of Ablation Therapy on Barrett's Esophagus
To assess the effect of ablation therapy on Barrett's esophagus. Proposal Ablation therapy
is an FDA approved treatment to decrease cancer risk in Barrett's esophagus mucosa. This is
being performed in our Barrett's Esophagus Unit on a regular basis. However, the longterm
outcomes of this therapy is not established and there are patients who have been treated who
later re-develop Barrett's mucosa. This study will allow us store tissue samples that can
later be used to assess the effect of ablative therapy on Barrett's esophagus.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Response to treatment
presence of persistent or recurrence of barrett's esophagus and/or dysplasia
at time of surveillance intervals
No
Kenneth K Wang, MD
Principal Investigator
Mayo Clinic
United States: Institutional Review Board
258-04
NCT00587314
January 2004
January 2015
Name | Location |
---|---|
Mayo Clinic | Rochester, Minnesota 55905 |